ArticleJournal of the Royal Society of Medicine2021

The US Food and Drug Administration's authorisation of Purdue's controlled-release methylphenidate for adult ADHD: comments on the regulatory practice.

Kim Boesen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.